AgNovos Bioscience Announces 150th Patient Enrolled in RESTORE
8/8/2023 | News
AgNovos Bioscience announces that more than 150 patients have been enrolled in the RESTORE randomized, controlled trial of AGN1 LOEP.
News & Events
Keep up to date on AgNovos events and related news
Archive - News
Corporate Rebranding Announcement
2/9/2023 | News
AgNovos Healthcare Announces Corporate Renaming as AgNovos Bioscience
AgNovos Healthcare to participate in 2022 British Orthopaedic Association Congress
9/19/2022 | News
AgNovos Healthcare is pleased to participate in this year’s British Orthopaedic Association Congress (BOA) from September 20-23 in Birmingham, England.
AgNovos Healthcare to Participate in German Society for Geriatric Traumatology Congress (Alterstraumatologie)
5/26/2022 | News
AgNovos Healthcare is pleased to participate in this year’s Alterstraumatologie congress in Munich, Germany from June 1-2nd.
2022 ESCEO-AgNovos Young Investigator Award
4/4/2022 | News
It is with great pleasure that AgNovos Healthcare announces the recipients of this year’s ESCEO-AgNovos Young Investigator Award presented at World Congress on Osteoporosis in March 2022.
AgNovos Healthcare Completes Enrollment for CONFIRM Clinical Study
1/11/2022 | News
AgNovos Healthcare is pleased to announce the completion of enrollment for its CONFIRM clinical study.